Building regulatory and ethics expertise for Experimental Medicine

This webinar explored the needs, optimal methods and practical approaches for improving knowledge and capabilities of health products that regulatory authorities, agencies and ethics review committees use to assess experimental medicine clinical research in high-income and low- and middle-income countries.

Watch part one of the event here and part two here.

20 September 2022
Chair
Cathy Slack

Cathy Slack

Head of the HIV AIDS Vaccines Ethics Group

University of KwaZulu-Natal, RSA

Speakers
Bartholomew Dicky Akanmori

Bartholomew Dicky Akanmori

WHO Regional Office for Africa Regional Advisor

Vaccine Regulation and Safety Communicable and Non-Communicable Disease (UCN) Cluster, Vaccine Preventable Diseases (VPD) Program. Brazzaville, Congo

Eric Karikari - Boateng

Eric Karikari - Boateng

Director

Centre for Laboratory Services and Research, FDA, Ghana

Gavin Churchyard

Gavin Churchyard

CEO

The Aurum Institute NPC, RSA

Jerome Singh

Jerome Singh

University of KwaZulu-Natal

Julien Nyombayire

Julien Nyombayire

Country Director

Project San Francisco